Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Alvarez Diego F

From Bioblast
Revision as of 14:25, 18 May 2022 by Tindle Lisa (talk | contribs) (Created page with "{{Person |lastname=Alvarez |firstname=Diego F |title=MD, PhD |institution= Department of Physiology & Pharmacology<br> Sam Houston State University <br> College of Osteopat...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Name Alvarez Diego F, MD, PhD
Institution Department of Physiology & Pharmacology

Sam Houston State University
College of Osteopathic Medicine

Texas, US

Address 925 City Central Avenue, TX 77304
City Conroe
State/Province
Country USA
Email diego.alvarez@shsu.edu
Weblink
O2k-Network Lab


Labels:



Publications

 PublishedReference
Audia 2018 Basic Res Cardiol2018Audia JP, Yang XM, Crockett ES, Housley N, Haq EU, O'Donnell K, Cohen MV, Downey JM, Alvarez DF (2018) Caspase‑1 inhibition by VX‑765 administered at reperfusion in P2Y12 receptor antagonist‑treated rats provides long‑term reduction in myocardial infarct size and preservation of ventricular function. Basic Res Cardiol 113:32.
Yuzefovych 2013 Endocrinology2013Yuzefovych LV, Schuler AM, Chen J, Alvarez DF, Eide L, Ledoux SP, Wilson GL, Rachek LI (2013) Alteration of mitochondrial function and insulin sensitivity in primary mouse skeletal muscle cells isolated from transgenic and knockout mice: role of OGG1. Endocrinology 154:2640-9.

Abstracts

 PublishedReference
Alvarez 2022 Bioblast20222022Participant: Bioblast 2022 and NextGen-O2k Workshop.